Jailani, Jernalyn I.
HRN: 20-61-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2023
MUPIROCIN 2%, 15G (TUBE)
04/09/2023
04/15/2023
TOPICAL
2ml
BID
Wound Site Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes